See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $469B | 7.7x | 18.2x | |
| $363B | 4.2x | 15.3x | |
| $235B | 4.5x | 18.8x | |
| $170B | 2.5x | 11.5x | |
| $80.7B | 1.5x | 7.2x | |
| $71.4B | 3.5x | 14.5x | |
| $65.7B | 3.4x | 12.4x | |
| $59.2B | 8.2x | 35.5x | |
| $55.4B | 3.7x | 14.8x | |
| $50.7B | 9.7x | 42.3x | |
| $45.3B | 3.1x | 21.3x | |
| $42.6B | 4.5x | 18.4x | |
| $41.2B | 2.7x | 12.3x | |
| $33.5B | 1.4x | 7.6x | |
| $29.3B | 2.4x | 16.0x | |
| $22.7B | 1.5x | 8.1x | |
| $22.3B | 2.1x | 6.1x | |
| $22.2B | 3.6x | 15.8x | |
| $21.5B | 1.9x | 10.6x | |
| $17.8B | 1.7x | 10.9x | |
| $14.0B | 8.2x | 39.9x | |
| $12.6B | 2.1x | 14.4x | |
| $11.3B | 1.9x | 9.4x | |
| $10.6B | 7.4x | 41.3x | |
| $10.5B | 6.7x | 26.8x | |
| $9.5B | 6.5x | 34.5x | |
| $8.1B | 1.3x | 7.5x | |
| $7.3B | 1.2x | 13.4x | |
| $6.9B | 1.2x | 6.7x | |
| $6.1B | 9.0x | 28.1x | |
| $5.9B | 2.8x | 15.8x | |
| $5.8B | 6.0x | 23.2x | |
| $5.3B | 3.5x | 17.5x | |
| $5.1B | 1.2x | 7.0x | |
| $4.7B | 1.6x | 10.8x | |
| $4.7B | 9.4x | 36.7x | |
| $4.6B | 1.6x | 6.8x | |
| $4.3B | 10.0x | 30.5x | |
| $4.1B | 1.3x | 7.0x | |
| $3.9B | 3.5x | 10.7x | |
| $3.7B | 1.2x | 7.4x | |
| $3.6B | 3.0x | 18.4x | |
| $3.6B | 1.7x | 10.3x | |
| $3.3B | 3.8x | 9.4x | |
| $3.3B | 2.0x | 11.2x | |
| $3.1B | 1.5x | 10.5x | |
| $2.9B | 8.7x | 32.6x | |
| $2.8B | 1.9x | 9.2x | |
| $2.7B | 0.7x | 5.0x | |
| $2.6B | 0.6x | 5.2x | |
| $2.6B | 2.5x | 11.0x | |
| $2.6B | 1.0x | 7.6x | |
| $2.5B | 5.7x | 21.6x | |
| $2.5B | 1.0x | 5.3x | |
| $2.3B | 2.9x | 14.2x | |
| $2.3B | 4.0x | 19.7x | |
| $2.2B | 0.5x | 6.3x | |
| $2.1B | 5.5x | 16.0x | |
| $2.0B | 0.9x | 6.6x | |
| $1.9B | 2.5x | 17.7x | |
| $1.9B | 1.7x | 12.3x | |
| $1.9B | 2.7x | 12.7x | |
| $1.7B | 1.0x | 8.9x | |
| $1.6B | 0.9x | 6.8x | |
| $1.6B | 2.1x | 10.6x | |
| $1.6B | 6.0x | 16.9x | |
| $1.5B | n/a | n/a | |
| $1.4B | 0.7x | 7.6x | |
| $1.4B | 0.8x | 6.5x | |
| $1.4B | 1.1x | 7.7x | |
| $1.4B | 1.8x | 7.5x | |
| $1.3B | 0.6x | 5.7x | |
| $1.1B | 1.5x | 10.0x | |
| $1.0B | 2.4x | 11.2x | |
| $1.0B | 8.0x | 30.0x | |
| $1.0B | 4.0x | 57.9x | |
| $936M | 0.8x | 7.7x | |
| $837M | 1.8x | 8.7x | |
| $802M | 1.0x | 5.2x | |
| $730M | n/a | n/a | |
| $671M | n/a | n/a | |
| $622M | 0.2x | 1.4x | |
| $591M | 0.8x | 4.0x | |
| $575M | 0.8x | 6.5x | |
| $548M | 1.3x | 7.8x | |
| $544M | 1.8x | -25.8x | |
| $533M | n/a | n/a | |
| $515M | 3.0x | 11.9x | |
| $512M | 0.3x | n/a | |
| $427M | 1.6x | 19.4x | |
| $384M | 1.9x | -41.2x | |
| $352M | 0.8x | 10.0x | |
| $342M | 1.2x | 9.2x | |
| $333M | n/a | n/a | |
| $303M | n/a | n/a | |
| $302M | n/a | n/a | |
| $237M | 0.6x | 10.7x | |
| $221M | n/a | n/a | |
| $220M | 4.3x | 16.6x | |
| $211M | 0.4x | 12.3x | |
| $204M | 1.4x | 6.2x | |
| $195M | 2.4x | 13.8x | |
| $185M | 0.9x | 9.1x | |
| $175M | 0.9x | 3.9x | |
| $155M | 0.8x | 5.6x | |
| $151M | 0.6x | 6.1x | |
| $142M | n/a | n/a | |
| $141M | n/a | n/a | |
| $139M | 2.2x | 8.1x | |
| $128M | 0.5x | 5.8x | |
| $78.8M | n/a | n/a | |
| $63.8M | 0.3x | 6.8x | |
| $60.5M | 2.3x | 9.7x | |
| $46.6M | n/a | n/a | |
| $42.7M | n/a | n/a | |
| $39.5M | n/a | n/a | |
| $30.5M | 0.7x | n/a | |
| $28.9M | n/a | n/a | |
| $27.4M | 2.2x | n/a | |
| $24.8M | n/a | n/a | |
| $24.0M | 1.2x | -14.0x | |
| $23.7M | n/a | n/a | |
| $18.0M | n/a | n/a | |
| $17.5M | n/a | n/a | |
| $13.5M | n/a | n/a | |
| $6.2M | n/a | n/a | |
| $5.4M | n/a | n/a | |
| $1.2M | n/a | n/a | |
| -$45.4M | -0.1x | -75.7x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty